For instance, metformin, a drug used to treat diabetes, suppresses the expression of MITF and melanogenic genes by reducing cAMP/PKA/CREB signaling, thereby inhibiting melanin production in vivo and in human reconstituted epidermis [24]. Here, CREB1 is linked to diabetes mellitus.